Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Net Margin

ELI LILLY AND COMPANY (LLY) Net Margin

  • 2026-06-30: Net Margin 30.88%.
  • 2026-03-31: Net Margin 37.36%.
  • 2025-12-31: Net Margin 34.41%.
  • 2025-09-30: Net Margin 31.72%.

Complete source-backed net margin history.

Available history
2007-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3030.88%
2026-03-3137.36%
2025-12-3134.41%
2025-09-3031.72%
2025-06-3036.39%
2025-03-3121.67%
2024-12-3132.59%
2024-09-308.48%
2024-06-3026.25%
2024-03-3125.58%
2023-12-3123.41%
2023-09-30-0.60%
2023-06-3021.21%
2023-03-3119.32%
2022-12-3126.54%
2022-09-3020.91%
2022-06-3014.68%
2022-03-3124.36%
2021-12-3121.58%
2021-09-3016.39%
2021-06-3020.63%
2021-03-3119.91%
2020-12-3128.45%
2020-09-3021.05%
2020-06-3025.68%
2020-03-3124.86%
2019-12-3124.46%
2019-09-3022.90%
2019-06-3023.55%
2019-03-3183.30%
2018-12-3119.96%
2018-09-3021.66%
2018-06-30-4.65%
2018-03-3124.53%
2017-12-31-50.78%
2017-09-309.82%
2017-06-3017.31%
2017-03-31-2.12%
2016-12-3113.40%
2016-09-3014.99%
2016-06-3013.83%
2016-03-319.05%
2015-12-318.90%
2015-09-3016.12%
2015-06-3012.07%
2015-03-3111.40%
2014-12-318.37%
2014-09-3010.27%
2014-06-3014.86%
2014-03-3115.54%
2013-12-3112.52%
2013-09-3020.84%
2013-06-3020.34%
2013-03-3127.63%
2012-12-3113.89%
2012-09-3024.37%
2012-06-3016.49%
2012-03-3118.05%
2011-12-3114.19%
2011-09-3020.11%
2011-06-3019.15%
2011-03-3118.08%
2010-12-3118.90%
2010-09-3023.04%
2010-06-3023.46%
2010-03-3122.75%
2009-12-3115.43%
2009-09-3016.93%
2009-06-3021.89%
2009-03-3126.02%
2008-12-31-69.74%
2008-09-30-8.94%
2008-06-3018.62%

Annual Net Margin

DateNet Margin
2025-12-3131.67%
2024-12-3123.51%
2023-12-3115.36%
2022-12-3121.88%
2021-12-3119.71%
2020-12-3125.24%
2019-12-3137.27%
2018-12-3115.04%
2017-12-31-1.02%
2016-12-3112.90%
2015-12-3112.07%
2014-12-3112.19%
2013-12-3120.27%
2012-12-3118.09%
2011-12-3117.90%
2010-12-3121.97%
2009-12-3119.82%
2008-12-31-10.17%
2007-12-3115.85%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94